Laxmi Cotspin
: LAXMICOT · Other Textile Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Laxmi Cotspin's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Laxmi Cotspin Ltd is primarily engaged in the cotton ginning and spinning industry, producing combed cotton wrap and hosiery yarns. The company is currently diversifying its operations into the healthcare and medical textile sectors.
Business Model
The company generates revenue through the manufacturing and sale of cotton yarn, cotton bales, oil cake, and oil seeds. It is transitioning towards a broader portfolio that includes medical textiles and potential garment manufacturing.
Management Commentary
Management is focused on strategic diversification into the healthcare sector, with commercial production for this new division scheduled to commence in FY26.
Growth Outlook
Growth is expected to be driven by the establishment of a surgical division and the planned expansion into medical textiles. Additionally, the company is evaluating the feasibility of setting up a garment unit within its existing infrastructure.
- Healthcare production commencement:FY26
Key Risks
- Commodity Price Volatility. The company's profitability is highly sensitive to fluctuations in raw cotton prices.
- Execution Risk. Successful diversification into the healthcare and medical textile sectors depends on timely project implementation and market acceptance.
- Cyclicality. The textile industry is inherently cyclical and susceptible to changes in global demand and trade policies.
Start your research today
Unlock AI insights, financials, peers and live data on Laxmi Cotspin and 5,000+ companies — free.
Key Metrics
REVENUE
₹151 Cr
TTM · consolidated
NET PROFIT
₹-1 Cr
TTM · consolidated
EPS
₹-1.11
TTM · consolidated
RETURN ON EQUITY
-1.9%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
4.6%
TTM · consolidated
P/E
-13.5x
Q4 FY26 · consolidated
EV/EBITDA
15.2x
Q4 FY26 · consolidated
EBITDA MARGIN
2.8%
TTM · consolidated
NET PROFIT MARGIN
-8.3%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.7x
Q4 FY26 · consolidated
Peers · Other Textile Products
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Laxmi CotspinLAXMICOT | ₹23 Cr | -12.09 | 15.71 | 0.2% | 2.8% | -1.9% | 4.6% | -45.4% |
Raghuvir Synthetics Ltd.RAGHUSYN | ₹367 Cr | 25.24 | 17.63 | -23.3% | 9.7% | 41.8% | 25.5% | -23.0% |
Axita CottonAXITA | ₹308 Cr | 80.50 | 37.62 | -58.4% | 3.0% | 6.1% | 11.7% | -8.5% |
Vardhman PolytexVARDMNPOLY | ₹289 Cr | 0.91 | 13.84 | -15.2% | 10.4% | -150.1% | 279.9% | -33.4% |
R&B DenimsRNBDENIMS | ₹265 Cr | 4.87 | 6.45 | — | 10.8% | 10.5% | 12.5% | -89.7% |
Le Merite ExportLEMERITE | ₹262 Cr | — | — | — | 4.0% | — | — | -94.2% |
As of Q4 FY26
Financials
Laxmi Cotspin
: LAXMICOT · Other Textile Products
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Laxmi Cotspin's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Laxmi Cotspin Ltd is primarily engaged in the cotton ginning and spinning industry, producing combed cotton wrap and hosiery yarns. The company is currently diversifying its operations into the healthcare and medical textile sectors.
Business Model
The company generates revenue through the manufacturing and sale of cotton yarn, cotton bales, oil cake, and oil seeds. It is transitioning towards a broader portfolio that includes medical textiles and potential garment manufacturing.
Management Commentary
Management is focused on strategic diversification into the healthcare sector, with commercial production for this new division scheduled to commence in FY26.
Growth Outlook
Growth is expected to be driven by the establishment of a surgical division and the planned expansion into medical textiles. Additionally, the company is evaluating the feasibility of setting up a garment unit within its existing infrastructure.
- Healthcare production commencement:FY26
Key Risks
- Commodity Price Volatility. The company's profitability is highly sensitive to fluctuations in raw cotton prices.
- Execution Risk. Successful diversification into the healthcare and medical textile sectors depends on timely project implementation and market acceptance.
- Cyclicality. The textile industry is inherently cyclical and susceptible to changes in global demand and trade policies.
Start your research today
Unlock AI insights, financials, peers and live data on Laxmi Cotspin and 5,000+ companies — free.
Key Metrics
REVENUE
₹151 Cr
TTM · consolidated
NET PROFIT
₹-1 Cr
TTM · consolidated
EPS
₹-1.11
TTM · consolidated
RETURN ON EQUITY
-1.9%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
4.6%
TTM · consolidated
P/E
-13.5x
Q4 FY26 · consolidated
EV/EBITDA
15.2x
Q4 FY26 · consolidated
EBITDA MARGIN
2.8%
TTM · consolidated
NET PROFIT MARGIN
-8.3%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.7x
Q4 FY26 · consolidated
Peers · Other Textile Products
As of Q4 FY26